Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: The role of clinical, psychosocial and genetic variables

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 3, 2006, Pages 442-448

  Dotoli, Danilo ^a   Spagnolo, Chiara ^a   Bongiorno, Fanny ^a   Zanardi, Raffaella ^a   Serretti, Alessandro ^a   Smeraldi, Enrico ^a   Franchini, Linda ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Fluvoxamine; Relapse; Social adjustment

Indexed keywords

FLUVOXAMINE; SEROTONIN TRANSPORTER; TRANSCRIPTION FACTOR CLOCK;

ADULT; ARTICLE; CLINICAL ASSESSMENT; DEPRESSION; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; HEREDITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PSYCHIATRIST; RELAPSE; REMISSION; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER, MAJOR; DNA MUTATIONAL ANALYSIS; FEMALE; FLUVOXAMINE; FOLLOW-UP STUDIES; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33646054531     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.11.020     Document Type: Article

References (72)

1. Abe H., Honma S., Namihira M., Tanahashi Y., Ikeda M., and Honma K. Circadian rhythm and light responsiveness of BMAL1 expression, a partner of mammalian clock gene Clock, in the suprachiasmatic nucleus of rats. Neurosci Lett 258 (1998) 93-96
2. Alnaes R., and Torgersen S. Personality and personality disorders predict development and relapses of major depression. Acta Psychiatr Scand 95 (1997) 336-342
3. Angst J., Kupfer D.J., and Rosenbaum J.F. Recovery from depression: risk or reality?. Acta Psychiatr Scand 93 (1996) 413-419
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fourth ed. (1994), American Psychiatric Press, Washington
5. Artioli P., Serretti A., Lattuada E., Lorenzi C., Lilli R., and Smeraldi E. Clinical and genetic features of antidepressant induced mania in bipolar disorder. Xth World Congr. Psychiatric Gen. Brussels (2002) 755
6. Bauwens F., Tracy A., Pardoen D., Vanderelst M., and Mendlewicz J. Social adjustment of remitted bipolar and unipolar outpatients. A comparison with age- and sex-matched controls. Br J Psychiatry 159 (1991) 239-244
7. Bauwens F., Pardoen D., Staner L., Dramaix M., and Mendlewicz J. Social adjustment and the course of affective illness: a one-year controlled longitudinal study involving bipolar and unipolar outpatients. Depress Anxiety 8 (1998) 50-57
8. Bech P., Malt U., Dencker S., Ahlfors U., Elgen K., and Lewander T. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand 87 Suppl. 372 (1993) S37-S40
9. Belsher G., and Costello C.G. Relapse after recovery from unipolar depression: a critical review. Psychol Bull 104 (1988) 84-96
10. Benedetti F., Serretti A., Colombo C., Barbibi B., Lorenzi C., Campori E., et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet 123 (2003) 23-26
11. Blairy S., Linotte S., Souery D., Papadimitriou G.N., Dikeos D., Lerer B., et al. Social adjustment and self-esteem of bipolar patients: a multicentric study. J Affect Disord 79 (2004) 97-103
12. Brown G.W., Bifulco A., and Andrews B. Self-esteem and depression: IV. Effect on course and recovery. Soc Psychiatry Psychiatr Epidemiol 25 (1990) 244-249
13. Brown G.W., Harris T.O., Hepworth C., and Robinson R. Clinical and psychosocial origins of chronic depressive episodes: II. A patient enquiry. Br J Psychiatry 165 (1994) 457-465
14. Brown C., Schulberg H.C., and Prigerson H.G. Factors associated with symptomatic improvement and recovery from major depression in primary care patients. Gen Hosp Psychiatry 22 (2000) 242-250
15. Brugha T., Bebbington P., MacCarthy B., Sturt E., Wykes T., and Potter J. Gender, social support and recovery from depressive disorders: a prospective clinical study. Psychol Med 20 (1990) 147-156
16. Cohen J. Statistical power analysis for the behavioral sciences (1988), Lawrence Erlbaum Associates, Hillsdale (NJ)
17. Coryell W., Leon A., Winoker G., Endicott J., Keller M., Akiskal H., et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 153 (1996) 483-489
18. Cusin C., Serretti A., Lattuada E., Lilli R., Lorenzi C., Mandelli L., et al. Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders. J Psychiatry Res 35 (2001) 217-223
19. Duggan C., Lee A.S., and Murray R.M. Do different sub-types of hospitalized depressives have different outcomes?. Arch Gen Psychiatry 48 (1991) 308-312
20. Duggan C., Sham P., Minne C., Lee A.S., and Murray R.M. Family history as a predictor of poor long-term outcome in depression. Br J Psychiatry 173 (1998) 527-530
21. Ezquiaga E., Garcia A., Pallares T., and Bravo M.F. Psychosocial predictors of outcome in major depression: a prospective 12 month study. J Affect Disord 52 (1999) 209-216
22. Ezquiaga E., Garcia A., de Dios C., Leiva A., Bravo M., and Montejo J. Clinical and psychosocial factors associated with the outcome of unipolar major depression: a one-year prospective study. J Affect Disord 79 (2004) 63-70
23. Fava G.A., Ruini C., and Sonino N. Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach. CNS Drugs 17 (2003) 1109-1117
24. Franchini L., Gasperini M., Perez J., Smeraldi E., and Zanardi R. A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression. J Clin Psychiatry 58 (1997) 104-107
25. Franchini L., Zanardi R., Gasperini M., and Smeraldi E. Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate. J Clin Psychiatry 60 (1999) 861-865
26. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
27. Hinrichsen G.A., and Hernandez N.A. Factors associated with recovery from and relapse into major depressive disorder in the elderly. Am J Psychiatry 150 (1993) 1820-1825
28. Hirschfeld R.M. Clinical importance of long-term antidepressant treatment. Br J Psychiatry 42 (2001) 4-8
29. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., et al. Major depressive disorder: a prospective study of residual subthreshold symptoms as predictor of rapid relapse. J Affect Disord 50 (1998) 97-108
30. Judd L.L., Paulus M.P., Schettler P.J., Akiskal H.S., Endicott J., Leon A.C., et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?. Am J Psychiatry 157 (2000) 1501-1504
31. Keitner G.J., Ryan C.E., Miller I.W., Kohn R., and Epstein N.B. 12 month outcome of patients with depression and comorbid psychiatric or medical illness. Am J Psychiatry 148 (1991) 345-350
32. Keller M.B., Lavori P.W., Lewis C.E., and Klerman G.L. Predictors of relapse in major depressive disorder. JAMA 250 (1983) 3299-3304
33. Kennedy N., Abbott R., and Paykel E.S. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med 33 (2003) 827-838
34. Kupfer D.J., and Frank E. Minimum length of treatment for recovery. In: Montgomery S., and Rouillon F. (Eds). Long-term treatment of depression (1992), Wiley, New York 33-52
35. Lahiri D.K., and Nurnberger J.I.J. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 (1991) 5444
36. Lin E.H., Katon W.J., VonKorff M., Russo J.E., Simon G.E., Bush T.M., et al. Relapse of depression in primary care. Rate and clinical predictors. Arch Fam Med 7 (1998) 443-449
37. Mazure C.M., Bruce M.L., Maciejewski P.K., and Jacobs S.C. Adverse life events and cognitive-personality characteristics in the prediction of major depression and antidepressant response. Am J Psychiatry 157 (2000) 896-903
38. Melfi C.A., Chawla A.J., Croghan T.W., Hanna M.P., Kennedy S., and Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 55 (1998) 1128-1132
39. Mignone F., Gissi C., Liuni S., and Pesole G. Untranslated regions of mRNAs. Genome Biol 3 (2002) [REVIEWS0004]
40. Monroe S.M., Kupfer D.J., and Frank E. Life stress and treatment course of recurrent depression: I. Response during index episode. J Consult Clin Psychol 60 (1992) 718-724
41. Montgomery S.A., Doogan D.P., and Burnside R. The influence of different relapse criteria on the assessment of long-term efficacy of sertraline. Int Clin Psychopharmacol 6 Suppl. 2 (1991) S37-S46
42. Moos R.H., Cronkite R.C., and Moos B.S. Family and extrafamily resources and the 10-year course of treated depression. J Abnorm Psychol 107 (1998) 450-460
43. Mundo E., Walker M., Cate T., Macciardi F., and Kennedy J.L. The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder. Arch Gen Psychiatry 58 (2001) 539-544
44. Mundt C., Reck C., Backenstrass M., Kronmuller K., and Fiedler P. Reconfirming the role of life events for the timing of depressive episodes. A 2-year prospective follow-up study. J Affect Disord 59 (2000) 23-30
45. O'Leary D.A., and Lee A.S. Seven year prognosis in depression. Mortality and readmission risk in the Nottingham ECT cohort. Br J Psychiatry 169 (1996) 423-429
46. O'Reilly R.L., Bogue L., and Singh S.M. Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biol Psychiatry 36 (1994) 467-471
47. Orsini A. Antidepressant responses and segregation analyses in affective families. In: Racagni G., and Smeraldi E. (Eds). Anxious depression: assessment and treatment (1987), Raven Press, New York
48. Patience D., McGuire R., Scott A., and Freeman C. The Edinburgh primary care depression study: personality disorder and outcome. Br J Psychiatry 167 (1995) 324-330
49. Paykel E.S., Ramana R., Cooper Z., Hayhurst H., Kerr J., and Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25 (1995) 1171-1180
50. Pfohl B., Stanol D., and Zimmerman M. The implications of DSM-III personality disorders for patients with major depression. J Affect Disord 7 (1984) 309-318
51. Pincus H.A., and Pettit A.R. The societal costs of chronic major depression. J Clin Psychiatry 62 Suppl. 6 (2001) S5-S9
52. Pollock B.G., Ferrell R.E., Mulsant B.H., Mazumdar S., Miller M., Sweet R.A., et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23 (2000) 587-590
53. Ramana R., Paykel E., Cooper Z., Hayhurst H., Saxty M., and Surtees P. Remission and relapse in major depression: a 2-year prospective follow-up study. Psychol Med 25 (1995) 1161-1170
54. Rounsaville B.J., Prusoff B.A., and Weissman M.M. The course of marital disputes in depressed women: a 48-month follow-up study. Compr Psychiatry 21 (1980) 111-118
55. Rousseva A., Henry C., Van Den Bulke D., Fournier G., Laplanche J.L., Leboyer M., et al. Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Pharmacogenomics J 3 (2003) 101-104
56. Schulberg H.C., McClelland M., and Gooding W. Six month outcomes for medical patients with major depressive disorders. J Gen Intern Med 2 (1987) 312-317
57. Serretti A., Cavallini M.C., Macciardi F., Namia C., Franchini L., Souery D., et al. Social adjustment and self esteem in remitted patients with mood disorder. Eur Psychiatry 14 (1999) 137-142
58. Serretti A., Benedetti F., Mandelli L., Lorenzi C., Pirovano A., Colombo C., et al. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. Am J Med Genet 121 (2003) 39-43
59. Serretti A., Zanardi R., Franchini L., Artioli P., Dotoli D., Pirovano A., et al. Pharmacogenetics of SSRI response: a 6-month follow-up. Pharmacogenetics 14 (2004) 1-7
60. Shapira B., Zislin J., Gelfin Y., Osher Y., Gorfine M., Souery D., et al. Social adjustment and self-esteem in remitted patients with unipolar and bipolar affective disorder: a case-control study. Compr Psychiatry 40 (1999) 24-30
61. Simon G.E. Long-term prognosis of depression in primary care. Bull World Health Organ 78 (2000) 439-445
62. Smeraldi E., Zanardi R., Benedetti F., Dibella D., Perez J., and Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3 (1998) 508-511
63. Smeraldi E., Benedetti F., and Zanardi R. Serotonin transporter promoter genotype and illness recurrence in mood disorders. Eur Neuropsychopharmacol 12 (2002) 73-75
64. Spadone C. Treatment adherence in the recurrent depressive disorders. Encephale 28 (2002) 255-259
65. Steeves T.D., King D.P., Zhao Y., Sangoram A.M., Du F., Bowcock A.M., et al. Molecular cloning and characterization of the human CLOCK gene: expression in the suprachiasmatic nuclei. Genomics 57 (1999) 189-200
66. Surtees P.G., and Wainwright N.W.J. Fragile states of mind: neuroticism, vulnerability and the long-term outcome of depression. Br J Psychiatry 169 (1996) 338-347
67. Vallejo J., Gasto C., Catalan R., Bulbena A., and Menchon J.M. Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators. J Affect Disord 21 (1991) 151-162
68. Veiel H.O., Kuhner C., Brill G., and Ihle W. Psychosocial correlates of clinical depression after psychiatric inpatient treatment: methodological issues and baseline differences between recovered and non-recovered patients. Psychol Med 22 (1992) 415-427
69. Weissman M.M., and Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 33 (1976) 1111
70. Weissman M.M., Prusoff B.A., and Klerman G.L. Personality and the prediction of long-term outcome of depression. Am J Psychiatry 135 (1978) 797-800
71. Yu Y.W., Tsai S.J., Chen T.J., Lin C.H., and Hong C.J. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7 (2002) 1115-1119
72. Zanardi R., Serretti A., Rossini D., Franchini L., Cusin C., Lattuada E., et al. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and non-delusional depression. Biol Psychiatry 50 (2001) 323-330